Endocrine disruptor assessment list

Endocrine disruptor assessment list

Endocrine disruptor assessment list

ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment that have been brought for discussion to ECHA’s ED Expert Group.

Explanatory note

Inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since February 2013.

For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.

Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.

One possible outcome of such an assessment is that a substance is considered not to have ED properties.

If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under is needed before any regulatory action can be taken due to these properties.

The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.

Disclaimer

The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.

Last updated 24 June 2024. Database contains 121 unique substances/entries.
Filter the list
Date of hazard assessment:
Date of intention:
Latest update:

The List does not contain any Substances.
 
231-511-9
7601-89-0
Germany
Concluded
ED ENV
03-Feb-2021
Details
231-195-2
7446-09-5
Germany
Under development
Under development (BPR)
03-Feb-2021
Details
231-711-6
7696-12-0
Germany
Under development
Under development (BPR)
03-Feb-2021
Details
200-838-9
75-09-2
Italy
Concluded
postponed
03-Sep-2021
Details
246-678-3
25155-25-3
Netherlands
Under development
Under development (SEV)
14-Aug-2023
Details
219-006-1
2312-35-8
Netherlands
Concluded
postponed
23-Jan-2023
Details
200-712-3
69-72-7
Netherlands
Under development
Under development (BPR)
15-Sep-2023
Details
200-849-9
75-21-8
Norway
Under development
Under development (BPR)
03-Feb-2021
Details
811-718-6
86347-14-0
Norway
Under development
Under development (BPR)
15-Sep-2023
Details
240-016-7
15879-93-3
Poland
Under development
Under development (BPR)
03-Feb-2021
Details
602-782-4
122453-73-0
Portugal
Under development
Under development (BPR)
04-Apr-2024
Details
212-950-5
886-50-0
Slovakia
Under development
Under development (BPR)
03-Feb-2021
Details
627-872-0
1514-82-5
Spain
Concluded
postponed
23-Jan-2023
Details
200-143-0
52-51-7
Spain
Under development
Under development (BPR)
15-Mar-2023
Details
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
289-699-3
89997-63-7
Spain
Under development
Under development (BPR)
05-Feb-2021
Details
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
289-699-3
89997-63-7
Spain
Under development
Under development (BPR)
05-Feb-2021
Details
201-289-8
80-54-6
Sweden
Concluded
inconclusive
10-Mar-2022
Details
300-340-2
93925-38-3
Sweden
Under development under SEV
Under development (SEV)
25-Sep-2023
Details
234-217-9
10599-90-3
Sweden
Under development
Under development (BPR)
22-Oct-2021
Details
201-545-9
84-61-7
Sweden
Concluded
ED HH
03-Feb-2021
Details
201-545-9
84-61-7
Sweden
Concluded
ED ENV
04-Oct-2023
Details
231-131-3
7440-22-4
Sweden
Under development
Under development (BPR)
02-Jul-2021
Details
868-573-7
130328-19-7
Sweden
Under development
Under development (BPR)
03-Feb-2021
Details
ALPHASAN ANTIMICROBIAL RC 2000; ALPHASAN ANTIMICROBIAL RC 5000; NOVARON; SILVER SODIUM HYDROGEN ZIRCONIUM PHOSPHATE
422-570-3
155925-27-2
Sweden
Under development
Under development (BPR)
03-Feb-2021
Details
603-404-0
130328-20-0
Sweden
Under development
Under development (BPR)
03-Feb-2021
Details
205-286-2
137-26-8
Sweden
Concluded
not ED
24-Oct-2018
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
United Kingdom
Concluded
postponed
05-Nov-2021
Details
203-398-6
106-44-5
United Kingdom
Concluded
not ED
07-Mar-2017
Details

Export search results to: